89bio Inc (ETNB) — Financial Flexibility Index
89bio Inc (ETNB) has a Financial Flexibility Index of -1.23x as of June 2025. Free cash flow of $-100.42 Million (operating CF $-100.42 Million minus capex $0.00) represents -1% of total liabilities ($81.75 Million). Also explore ETNB net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
89bio Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for 89bio Inc across 7 annual periods. Check how strategically is 89bio Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for 89bio Inc (2018–2024)
Year-by-year free cash flow to debt coverage for 89bio Inc. For the full company profile including market capitalisation, see 89bio Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.72x | $-367.81 Million | $-367.82 Million | $77.90 Million | ▼ -119.2% |
| 2023 | -2.15x | $-129.18 Million | $-129.19 Million | $59.96 Million | ▼ -19.5% |
| 2022 | -1.80x | $-81.08 Million | $-81.09 Million | $44.99 Million | ▲ +14.3% |
| 2021 | -2.10x | $-76.72 Million | $-76.78 Million | $36.47 Million | ▲ +63.0% |
| 2020 | -5.68x | $-46.12 Million | $-46.24 Million | $8.11 Million | ▼ -25.9% |
| 2019 | -4.51x | $-25.32 Million | $-25.46 Million | $5.61 Million | ▼ -896.1% |
| 2018 | -0.45x | $-12.43 Million | $-12.47 Million | $27.43 Million | — |